Daiichi Sankyo has taken a step forward in expanding its interest in RNA-based t...
Pfizer and Arvinas reported that their estrogen receptor degrader failed to meet...
Merck has inaugurated a fresh $1 billion, 225,000-square-foot manufacturing site...
China-based Harbour BioMed has recently announced the establishment of a new bio...
The Durham complex of Merck now operates a new $1 billion, massive 225,000-squar...
Merck KGaA has faced a challenge in the clinical evaluation of its investigation...
The phase 1 T-cell engager developed by Amgen and CytomX Therapeutics was termin...
The drug company Glenmark Pharma, which is located in India and has been the sub...
The U.S. Food and Drug Administration (FDA) has placed a hold on BioNTech’s phas...
Regeneron has adjusted its regulatory approach for odronextamab, opting to pursu...
Teleflex has announced plans to restructure its operations by creating two indep...
Silence Therapeutics recently shared an update regarding its zerlasiran program,...
The Food and Drug Administration (FDA) has canceled its advisory panel meeting o...
Roche has proposed a fresh kind of genetic analysis. This process, which the com...
After Mirum Pharmaceuticals spent $210 million to acquire Travere Therapeutics’ ...
Eleven children who were born legally blind experienced significant improvements...
